Want to join the conversation?
$MSM said that 2Q16 GM was 45.1%, at the high end of guidance & down about 30 BP from 2Q15. $MSM believes supplier cost reductions to have an increasing impact on GM moving through 2H16 & into FY17. 2Q16 OpEx was roughly $6.8MM lower vs. 2Q15, hurt by headcount-related savings, various cost reductions initiatives & lower volume-related expenses.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)